Ming Yin, MDThe James Cancer Center
- Female Urogenital Diseases
- Male Urogenital Diseases
- Medical Oncology
- Urogenital Abnormalities
- Urogenital Cancers
- Urogenital System
Make an Appointment
I’m a medical oncologist specializing in genitourinary medical oncology. I received my medical training at the Medical School of Nanjing University in China and completed my fellowship training at the Penn State University Hershey Medical Center, Pennsylvania. In addition, I completed a postdoctoral research fellowship in molecular epidemiology at the MD Anderson Cancer Center in Houston, Texas.
Currently, I serve as a member in the American College of Physicians, the American Association of Cancer Research and other professional organizations. My research focuses on the underlying mechanisms of cancer, and particularly, how DNA repair pathways modulate cancer susceptibility and treatment response. I have published a series of articles in this field in prestigious scientific journals, including the Journal of Clinical Oncology and Clinical Cancer Research.
I was drawn to oncology after losing my father to cancer and I’ve learned that cancer science is a life-long learning process. That’s why I enjoy working at the OSUCCC – James; we focus on multidisciplinary approaches with doctors from all fields to create individualized treatment plans for each patient. I believe in the power of compassion, and I work hard to provide knowledge, respect and the best possible treatment to each of my patients. The James makes all of that possible.
Education and Background
Nanjing University - School of Medicine
MD Anderson Cancer Center
Penn State Hershey Medical Center
- American Board of Internal Medicine
- Department of Internal Medicine
- Division of Medical Oncology
I see patients at
The James at Brain and Spine Hospital
300 West 10th Avenue, Columbus, Ohio 43210
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Yin has reported no financial relationships with medical device, research and/or drug companies.